Albany Molecular Research Inc. (AMRI) has signed a three-year collaborative agreement with biotechnology company HarkerBIO to co-market their drug discovery services to clients.
Galapagos has bolstered the portfolio of its BioFocus DPI contract services unit by purchasing the structure-based drug discovery business of UK firm Sareum.
Moscow, Russia-based Quantum Pharmaceuticals is offering
pharmaceutical and biotechnology companies the opportunity to test
the latest version of its molecular docking software - Quantum 2.0
- at no cost, reports Phil Taylor.